Cisplatin damage overrides the predefined rotational setting of positioned nucleosomes
- PMID: 17432860
- PMCID: PMC2501106
- DOI: 10.1021/ja0706145
Cisplatin damage overrides the predefined rotational setting of positioned nucleosomes
Abstract
Cisplatin and carboplatin are used successfully to treat various types of cancer. The drugs target the nucleosomes of cancer cells and form intrastrand DNA cross-links that are located in the major groove. We constructed two site-specifically modified nucleosomes containing defined intrastrand cis-{Pt(NH3)2}(2+) 1,3-d(GpTpG) cross-links. Histones from HeLa-S3 cancer cells were transferred onto synthetic DNA duplexes having nucleosome positioning sequences. The structures of these complexes were investigated by hydroxyl radical footprinting. Employing nucleosome positioning sequences allowed us to quantify the structural deviation induced by the cisplatin adduct. Our experiments demonstrate that a platinum cross-link locally overrides the rotational setting predefined in the nucleosome positioning sequence such that the lesion faces toward the histone core. Identical results were obtained for two DNA duplexes in which the sites of platination differed by approximately half a helical turn. Additionally, we determined that cisplatin unwinds nucleosomal DNA globally by approximately 24 degree. The intrastrand cis-{Pt(NH3)2}(2+) 1,3-d(GpTpG) cross-links are located in an area of the nucleosome that contains locally overwound DNA in undamaged reference nucleosomes. Because most nucleosome positions in vivo are defined by the intrinsic DNA sequence, the ability of cisplatin to influence the structure of these positioned nucleosomes may be of physiological relevance.
Figures








Similar articles
-
A 1,2-d(GpG) cisplatin intrastrand cross-link influences the rotational and translational setting of DNA in nucleosomes.J Am Chem Soc. 2008 Mar 5;130(9):2851-61. doi: 10.1021/ja710220x. Epub 2008 Feb 13. J Am Chem Soc. 2008. PMID: 18269283 Free PMC article.
-
Platinum anticancer drug damage enforces a particular rotational setting of DNA in nucleosomes.Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12311-6. doi: 10.1073/pnas.0506025102. Epub 2005 Aug 22. Proc Natl Acad Sci U S A. 2005. PMID: 16116097 Free PMC article.
-
Nucleotide excision repair from site-specifically platinum-modified nucleosomes.Biochemistry. 2003 Jun 10;42(22):6747-53. doi: 10.1021/bi034264k. Biochemistry. 2003. PMID: 12779329
-
Consequences of cisplatin binding on nucleosome structure and dynamics.Chem Biol. 2010 Dec 22;17(12):1334-43. doi: 10.1016/j.chembiol.2010.10.018. Chem Biol. 2010. PMID: 21168769 Free PMC article.
-
Interstrand cross-links of cisplatin induce striking distortions in DNA.J Inorg Biochem. 1999 Oct;77(1-2):23-9. doi: 10.1016/s0162-0134(99)00148-8. J Inorg Biochem. 1999. PMID: 10626349 Review.
Cited by
-
Monofunctional and higher-valent platinum anticancer agents.Inorg Chem. 2013 Nov 4;52(21):12234-49. doi: 10.1021/ic400538c. Epub 2013 Jun 5. Inorg Chem. 2013. PMID: 23738524 Free PMC article.
-
Effects of artemisinin and cisplatin on the malignant progression of oral leukoplakia. In vitro and in vivo study.J Cancer Res Clin Oncol. 2024 Aug 18;150(8):390. doi: 10.1007/s00432-024-05924-x. J Cancer Res Clin Oncol. 2024. PMID: 39154308 Free PMC article.
-
Enzymatic processing of platinated RNAs.J Am Chem Soc. 2010 Feb 17;132(6):1946-52. doi: 10.1021/ja908419j. J Am Chem Soc. 2010. PMID: 20099814 Free PMC article.
-
Effect of the Spiroiminodihydantoin Lesion on Nucleosome Stability and Positioning.Biochemistry. 2016 Apr 26;55(16):2411-21. doi: 10.1021/acs.biochem.6b00093. Epub 2016 Apr 13. Biochemistry. 2016. PMID: 27074396 Free PMC article.
-
Visualizing inhibition of nucleosome mobility and transcription by cisplatin-DNA interstrand crosslinks in live mammalian cells.Cancer Res. 2013 Jul 15;73(14):4451-60. doi: 10.1158/0008-5472.CAN-13-0198. Epub 2013 May 21. Cancer Res. 2013. PMID: 23695549 Free PMC article.
References
-
- Wong E, Giandomenico CM. Chem Rev. 1999;99:2451–2466. - PubMed
-
- Jamieson ER, Lippard SJ. Chem Rev. 1999;99:2467–2498. - PubMed
-
- Wang D, Lippard SJ. Nat Rev Drug Discovery. 2005;4:307–319. - PubMed
-
- Blommaert FA, van Dijk-Knijnenburg HCM, Dijt FJ, den Engelse L, Baan RA, Berends F, Fichtinger-Schepman AMJ. Biochemistry. 1995;34:8474–8480. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources